Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders

This study has been completed.
Autism Speaks
Information provided by (Responsible Party):
L. Eugene Arnold, Ohio State University Identifier:
First received: October 15, 2008
Last updated: April 7, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)